Considering that the presence of NASH is an indicator of long-term outcomes in NAFLD [37], the potential power of serum GP73 in the diagnosis of hepatic necroinflammatory diagnosis has important clinical significance. This evidence concerns the gene GOLM1 and metabolic dysfunction-associated steatotic liver disease.